The early stages of chronic kidney disease are usually asymptomatic, with diagnosis only achieved following blood or urine tests undertaken for another reason. Now, National Institute for Health and Care Excellence guidance is highlighting the value of these simple tests, which have been the focus of a recently published study.
PIP CKD ARTICLE web text (pp 37-38)
A simple blood and urine test can identify those most at risk of severe complications of chronic kidney disease. However, despite being recommended by the National Institute for Health and Care Excellence (NICE) in 2021, many patients and GPs remain unaware of the test’s life-saving potential. New research, led by the University of Glasgow and published in the British Journal of General Practice, assessed patient data from across the UK and found that not enough people with chronic kidney disease were routinely being given this recommended test. The study results have prompted renewed calls from kidney specialists to encourage more patients to be given access to this test.1
Chronic kidney disease
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
Register
